Locus Cell Co., Ltd. (TPEX:6891)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Cell Therapy-related Products	406.00K	Log In
Cell Therapy-related Products Growth	-32.33%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Taiwan	406.00K	Log In
Taiwan Growth	-32.33%	Log In